MOLECULAR MECHANISMS OF MAMMALIAN CHECKPOINT PATHWAYS
MOLECULAR MECHANISMS OF MAMMALIAN CHECKPOINT PATHWAYS
批准号:
6158876
负责人:
Christine Elizabeth Canman
金额:
$23.36万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-05-15 至 2005-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (From Abstract) Cell cycle checkpoints are surveillance mechanisms
that induce growth arrest responses to ensure genetic fidelity and stability.
Absence of checkpoint function can be associated with increased sensitivity to
ionizing radiation (IR) and with genetic diseases such as the cancer prone
disease ataxia telangiectasia that is caused by mutations within the ATM gene.
The genes required for yeast checkpoint functions are well known but have not
been fully characterized at the biochemical level. Human homologs for these
genes have now been identified and include the main effector proteins kinases
ATM and ATR; a complex of proteins believed to act upstream of ATM and ATR
(HuRad1, HuHus1, HuRad9, and HuRad1; and downstream effector kinases HuChk1 and
HuCds1 (Chk2) that appear to mediate growth arrest in G2 by targeting cdc25C.
It has been shown that HuCds1 is activated in an ATM-dependent manner in
response to IR. Experiments will be performed to determine whether ATM targets
HuCds1 in response to IR and whether HuCds1 is a major effector of
ATM-controlled pathways. Other mechanisms for the regulation of HuCds1 in
response to DNA damage will be explored by determining whether other proteins
bind to the fork head associated (FHA) domain of HuCds1 and modulate its
activity in response to DNA damage. To begin to understand the functions of
HuRad1, HuHus1, HuRad9, and HuRad17, dominant negative inhibitors will be
designed to disrupt HuRad17 function and the HuRad1, HuHus1, and HuRad9
complex. These inhibitors will be tested as to whether their expression in
cells interferes with the regulation of ATM kinase in response to IR and
produce AT-like checkpoint phenotypes. Defining the molecular functions of
these genes will not only improve our understanding of cell cycle regulation
following DNA damage, but may also identify new gene products that could be
targeted for the development of radiosensitizers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Mechanisms by which RAD18 and POLZ affect Response to Anticancer Agents
-
批准号:7759548
-
项目类别:
-
资助金额:$28.39万
-
财政年份:2008
-
负责人:Christine Elizabeth Canman
-
依托单位:
Novel mechanisms by which REV1 and POLZ affect response to anticancer agents
-
批准号:8827263
-
项目类别:
-
资助金额:$31.42万
-
财政年份:2008
-
负责人:Christine Elizabeth Canman
-
依托单位:
Novel Mechanisms by which RAD18 and POLZ affect Response to Anticancer Agents
-
批准号:7612024
-
项目类别:
-
资助金额:$28.39万
-
财政年份:2008
-
负责人:Christine Elizabeth Canman
-
依托单位:
Novel Mechanisms by which RAD18 and POLZ affect Response to Anticancer Agents
-
批准号:8212519
-
项目类别:
-
资助金额:$27.53万
-
财政年份:2008
-
负责人:Christine Elizabeth Canman
-
依托单位:
Novel mechanisms by which REV1 and POLZ affect response to anticancer agents
-
批准号:9012020
-
项目类别:
-
资助金额:$31.39万
-
财政年份:2008
-
负责人:Christine Elizabeth Canman
-
依托单位:
Novel mechanisms by which REV1 and POLZ affect response to anticancer agents
-
批准号:8696313
-
项目类别:
-
资助金额:$31.49万
-
财政年份:2008
-
负责人:Christine Elizabeth Canman
-
依托单位:
Novel Mechanisms by which RAD18 and POLZ affect Response to Anticancer Agents
-
批准号:8011716
-
项目类别:
-
资助金额:$27.53万
-
财政年份:2008
-
负责人:Christine Elizabeth Canman
-
依托单位:
海外基金